by Truveta staff | May 20, 2024 | Data
You probably know someone who will be diagnosed with prostate cancer in their lifetime. 1 in 8 men will develop prostate cancer, with a higher risk in Black and African American men and an overall increased risk after the age of 65. While most cases are not fatal,...
by Truveta Research | Aug 23, 2023 | Research, Research Insights
The United States has some of the highest rates of adverse maternal health outcomes compared to other high-income countries (Creanga et al., 2015; Gunja et al., 2022; Taylor et al., 2022). These outcomes have only increased in the last decade (Hoyert, 2023; U.S....
by Lisa Gurry, Chief Growth Officer | Jul 31, 2023 | Data
Rare diseases as a category aren’t that rare if you consider they impact 30 million Americans and 400 million people around the world. Not to mention their families, who often become caregivers. Yet, with nearly 7,000 rare diseases (identified as of today…), each is...
by Truveta staff | Jul 28, 2023 | Research
Scientists from the Institute for Systems Biology (ISB) have published new research in the JMIR Public Health and Surveillance journal. The work explores the National Institute of Health (NIH) recommendation for prophylactic anticoagulant use for pregnant patients...
by Truveta staff | Jun 20, 2023 | Technology
The Centers for Disease Control and Prevention reports that cardiovascular (CV) disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the US, with 805,000 dying yearly. Developing improved cardiovascular therapies is...